FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286293853> ?p ?o ?g. }

• W4286293853 endingPage "10049" @default.
• W4286293853 startingPage "10049" @default.
• W4286293853 abstract "10049 Background: Childhood cancer survivors (CCS) are at risk for radiotherapy (RT) late effects, including second malignancies. Optimal screening for thyroid cancer (TC) in CCS post-RT remains controversial. We assessed the clinical benefit of thyroid ultrasound (US) surveillance in CCS exposed to RT. Methods: 316 CCS (175 males) were prospectively surveilled with thyroid US between 2002 and 2021 at the Children’s Hospital of Philadelphia. Patients were screened upon referral to the Survivorship Program. Thyroid US, clinicopathologic features, and endocrine-related outcomes were ascertained. Outcomes were compared using primary CCS diagnosis age cohorts of ≤ 3, > 3 to ≤ 10, and > 10 years. Risk factors for thyroid nodule(s) and TC were evaluated using Kruskal Wallis and ANOVA [OR (95% CI)]. Results: The most common CCS diagnoses were leukemia (32%), CNS tumor (26%), and neuroblastoma (18%). Patients received TBI (43%) and/or RT to craniospinal (43%), chest (13%), and neck regions (7%). About 48% (n = 152) of patients presented thyroid nodule(s) (Table). Forty-six patients underwent surgery, and 28 had TC, including 19 with ATA low-risk, 2 with ATA intermediate-risk, and 7 with ATA high-risk disease. Of the 9 patients with intermediate- or high-risk disease, 5 were ≤ 3 years, 3 were > 3 to ≤ 10 years, and 1 was > 10 years at the time of RT exposure. Eight patients with TC demonstrated pathogenic variant(s). RT exposure at ≤ 3 years old conferred 2-fold increased risk for nodule(s) compared to RT at > 10 years [OR = 2.14 (1.44-2.84) p = 0.03]. Female sex [OR = 1.73 (1.25-2.21) p = 0.02] and greater interval between RT and first US [OR = 1.10 (1.04-1.15) p = 0.001] were additional independent risk factors. Conclusions: Younger age at RT exposure is associated with increased risk of and shorter latency for developing TC. Thyroid US surveillance appears most beneficial in CCS exposed to RT ≤ 3 years old in an effort to diagnose TC at an earlier stage prior to metastasis. [Table: see text]" @default.
• W4286293853 created "2022-07-21" @default.
• W4286293853 creator A5017202683 @default.
• W4286293853 creator A5044884305 @default.
• W4286293853 creator A5051664972 @default.
• W4286293853 creator A5053157289 @default.
• W4286293853 creator A5053915984 @default.
• W4286293853 creator A5068523255 @default.
• W4286293853 creator A5072298762 @default.
• W4286293853 creator A5074408723 @default.
• W4286293853 creator A5078658506 @default.
• W4286293853 creator A5084083780 @default.
• W4286293853 creator A5089407589 @default.
• W4286293853 date "2022-06-01" @default.
• W4286293853 modified "2023-09-27" @default.
• W4286293853 title "Thyroid gland definitive ultrasound screening in childhood cancer survivors following radiotherapy." @default.
• W4286293853 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.10049" @default.
• W4286293853 hasPublicationYear "2022" @default.
• W4286293853 type Work @default.
• W4286293853 citedByCount "0" @default.
• W4286293853 crossrefType "journal-article" @default.
• W4286293853 hasAuthorship W4286293853A5017202683 @default.
• W4286293853 hasAuthorship W4286293853A5044884305 @default.
• W4286293853 hasAuthorship W4286293853A5051664972 @default.
• W4286293853 hasAuthorship W4286293853A5053157289 @default.
• W4286293853 hasAuthorship W4286293853A5053915984 @default.
• W4286293853 hasAuthorship W4286293853A5068523255 @default.
• W4286293853 hasAuthorship W4286293853A5072298762 @default.
• W4286293853 hasAuthorship W4286293853A5074408723 @default.
• W4286293853 hasAuthorship W4286293853A5078658506 @default.
• W4286293853 hasAuthorship W4286293853A5084083780 @default.
• W4286293853 hasAuthorship W4286293853A5089407589 @default.
• W4286293853 hasConcept C121608353 @default.
• W4286293853 hasConcept C126322002 @default.
• W4286293853 hasConcept C141071460 @default.
• W4286293853 hasConcept C151730666 @default.
• W4286293853 hasConcept C187212893 @default.
• W4286293853 hasConcept C2776731575 @default.
• W4286293853 hasConcept C2779022025 @default.
• W4286293853 hasConcept C2779761222 @default.
• W4286293853 hasConcept C509974204 @default.
• W4286293853 hasConcept C526584372 @default.
• W4286293853 hasConcept C71924100 @default.
• W4286293853 hasConcept C86803240 @default.
• W4286293853 hasConceptScore W4286293853C121608353 @default.
• W4286293853 hasConceptScore W4286293853C126322002 @default.
• W4286293853 hasConceptScore W4286293853C141071460 @default.
• W4286293853 hasConceptScore W4286293853C151730666 @default.
• W4286293853 hasConceptScore W4286293853C187212893 @default.
• W4286293853 hasConceptScore W4286293853C2776731575 @default.
• W4286293853 hasConceptScore W4286293853C2779022025 @default.
• W4286293853 hasConceptScore W4286293853C2779761222 @default.
• W4286293853 hasConceptScore W4286293853C509974204 @default.
• W4286293853 hasConceptScore W4286293853C526584372 @default.
• W4286293853 hasConceptScore W4286293853C71924100 @default.
• W4286293853 hasConceptScore W4286293853C86803240 @default.
• W4286293853 hasIssue "16_suppl" @default.
• W4286293853 hasLocation W42862938531 @default.
• W4286293853 hasOpenAccess W4286293853 @default.
• W4286293853 hasPrimaryLocation W42862938531 @default.
• W4286293853 hasRelatedWork W2035292590 @default.
• W4286293853 hasRelatedWork W2115698750 @default.
• W4286293853 hasRelatedWork W2124371642 @default.
• W4286293853 hasRelatedWork W2145656159 @default.
• W4286293853 hasRelatedWork W2155240375 @default.
• W4286293853 hasRelatedWork W2911382163 @default.
• W4286293853 hasRelatedWork W3041682677 @default.
• W4286293853 hasRelatedWork W3092502801 @default.
• W4286293853 hasRelatedWork W4225386859 @default.
• W4286293853 hasRelatedWork W4290629096 @default.
• W4286293853 hasVolume "40" @default.
• W4286293853 isParatext "false" @default.
• W4286293853 isRetracted "false" @default.
• W4286293853 workType "article" @default.